---
title: "Proteomic prediction of disease largely reflects environmental risk exposure"
description: |
  * **Core Finding**: The high disease predictive value of the plasma proteome primarily reflects its sensitivity as a **quantitative readout of environmental risk factors** (like smoking and alcohol intake), rather than identifying proteins that are causal drivers of disease.
  * **Causality Assessment**: Using Mendelian Randomization (MR) on thousands of protein-disease associations in the UK Biobank, the study found **only 8%** showed suggestive evidence of a causal relationship, confirming that causal drivers are rare and disease-specific.
  * **Environmental Biomarkers**: The vast majority of non-causal proteins, particularly those broadly associated with multiple diseases, were found to be exposure-associated. The developed Proteomic Score for Smoking (SmokingPS) achieved an **AUC of 0.96**, validating the proteome's role as an objective, quantitative index of lifestyle behaviors.
date: last-modified
categories: [disease prediction, environmental risk factors, mendelian randomization, proteomics, smoking]
---
**PubMed:** [40909825](https://pubmed.ncbi.nlm.nih.gov/40909825/)
**DOI:** [10.1101/2025.08.27.25334571](https://doi.org/10.1101/2025.08.27.25334571)
**Overview generated by:** Gemini 2.5 Flash, 28/11/2025

## Introduction and Study Goal

Plasma proteomic signatures are highly effective at predicting disease risk, but the mechanisms behind their predictive value—whether they are causal **drivers** of disease or non-causal **predictors** reflecting upstream influences—are largely unknown. This study aims to characterize thousands of protein-disease associations to delineate proteins as potential therapeutic targets (drivers) or objective biomarkers of environmental risk factors.

## Study Design and Methods

The study utilized blood proteomic data from a subset of the **UK Biobank Pharma Proteomics Project (UKB-PPP)** (N=45,438) to investigate associations between 2,923 unique plasma proteins and 23 age-related incident disease outcomes.

### Partitioning Proteomic Biomarkers
The researchers employed a two-pronged approach to categorize protein-disease associations:

1.  **Causal Assessment (Drivers):** They applied **two-sample Mendelian Randomization (MR)** using **cis-pQTLs** as genetic instruments to identify which associations represented a potential causal effect of the protein on the disease.
2.  **Environmental Assessment (Predictors):** They tested non-causal proteins for associations with major modifiable environmental risk factors, focusing specifically on **smoking** and **alcohol intake** due to their large effects on common diseases.

### Exposure Quantification Scores
To quantify the sensitivity of the plasma proteome to lifestyle factors, the team developed a **Proteomic Score for Smoking (SmokingPS)** and an **AlcoholPS** using LASSO regression models trained on the UKB-PPP cohort. These scores were then tested for their ability to predict disease incidence.

## Key Findings: The Dominance of Environmental Signals

### 1. Causal Drivers are Rare and Disease-Specific
Initial analysis using Cox proportional hazards models identified a large number of associations (9,308 significant pairs involving 2,122 proteins and 22 diseases). However, MR analysis revealed that only a small subset—**8%**—of the protein-disease associations tested showed suggestive evidence for a causal relationship.

* **Specificity:** The proteins identified as putatively causal drivers were generally more likely to pertain to only a **single disease**, suggesting they represent disease-specific biological signals.
* **Therapeutic Implication:** These few MR-nominated proteins are critical for mechanistic characterization as they constitute promising therapeutic targets.

### 2. Predictive Value Reflects Environmental Exposure
The vast majority of protein-disease associations were classified as non-causal **predictors**. The study found that these proteins often broadly associate with incident disease because they are highly perturbed by environmental risk factors, suggesting their predictive value is as an **"environmental sensor."**

* **Smoking as a Major Driver:** The authors discovered that the vast majority (more than **90%**) of proteins associated with diseases like **lung cancer and COPD** are also significantly associated with smoking.
* **Quantitative Exposure Readouts:** The newly developed proteomic scores demonstrated high accuracy in quantifying environmental factors, achieving an **Area Under the Curve (AUC) of 0.96 for smoking** and **0.98 for alcohol intake**, confirming the plasma proteome's sensitivity as an objective index of exposure behavior.

## Conclusions and Recommendations

The study concludes that the plasma proteome's ability to predict disease is largely driven by its capacity to serve as a **quantitative readout of upstream environmental risk factors** rather than reflecting only disease-specific or causal processes. This work has significant implications for precision medicine:

1.  **Interpretation:** Researchers must clarify the roles of plasma protein measurements. Putatively causal proteins are candidates for **therapeutic targets**, while non-causal, exposure-associated proteins serve as valuable biomarkers for **monitoring the impacts of lifestyle and environment**.
2.  **Disease Prevention:** Proteomic assays offer a path toward measuring the effects of the environment on human health using objective, quantitative, and reproducible methods, which can help guide interventions for disease prevention.